Malignant Fibrous Histiocytoma: An Ultrastructural Perspective

References

• Fletcher CDM. Response to Letter to the Editor. Am J Surg Pathol. 1992;16:1023±1024.
   Google Scholar
• Hollowood K, Fletcher CDM. Malignant ®brous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol. 1995;12:210±220.
   Google Scholar
• Erlandson RA, Woodruff JM. Role of electron microscopy in the evaluation of soft tissue neoplasms, with emphasis on spindle cell and pleomorphic tumors. Hum Pathol. 1998;29:1372±1381.
   Google Scholar
• Hsu S-M, Raine L, Fanger H. Use of avidin±biotin±peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577±580.
   Google Scholar
• Ozello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and ®brous xanthomas. Cancer. 1963;16:331±344.
   Google Scholar
• O’Brien JE, Stout AP. Malignant ®brous xanthomas. Cancer. 1964; 17:1445±1456.
   Google Scholar
• Kempson RL, Kyriakos M. Fibroxanthosarcoma of the soft tissues: a type of malignant ®brous histiocytoma. Cancer. 1972;29:961±976.
   Google Scholar
• Dehner LP. Malignant ®brous histiocytoma: nonspeci®c morphologic pattern, speci®c pathologic entity, or both? Arch Pathol Lab Med. 1988;112:236±237.
   Google Scholar
• Weiss SW, Enzinger FM. Malignant ®brous histiocytoma: a analysis of 200 cases. Cancer. 1978;41:2250±2266.
   Google Scholar
• Weiss SW. Malignant ®brous histiocytoma: a reaf®rmation. Am J Surg Pathol. 1982;6:773±784.
   Google Scholar
• Jones MW, Norris HJ, Wargotz ES, Weiss SW. Fibrosarcoma-malignant ®brous histiocytoma of the breast: a clinicopathological study of 32 cases. Am J Surg Pathol. 1992;16:667±674.
   Google Scholar
• Cof®n CM, Dehner LP, Meis-Kindblom JM. In¯ammatory myo®broblastic tumor, in¯ammatory ®brosarocma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol. 1998;15:102±110.
   Google Scholar
• Granter SR, Badizadegan K, Fletcher CD. Myo®bromatosis in adults; glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol. 1998;22:513±525.
   Google Scholar
• Nielsen GP, Young RH, Dickersin GR, Rosenberg AE. Angiomyo®broblastoma of the vulva with sarcomatous transformation (``angiomyo®brosarcoma’’). Am J Surg Pathol. 1997;21:1104±1108.
   Google Scholar
• Grisaru D, Peyser MR, Bernstein-Lipschitz L, Yaron Y, Lessing JB. Malignant ®brous histiocytoma with myo®broblastic differentiation of the vulva in an adolescent female. Eur J Obstet Gynecol Reprod Biol. 1998;79:219±221.
   Google Scholar
• Hatano H, Tokunaga T, Ogose A, et al. Origin of histiocyte-like cells and multinucleated giant cells in malignant ®brous histiocytoma: neoplastic or reactive? Pathol Int. 1999;49:14±22.
   Google Scholar
• Hirose T, Kudo E, Hasegawa T, Abe J, Hizawa K. Expression of intermediate ®laments in malignant ®brous histiocytomas. Hum Pathol. 1989;20:871±877.
   Google Scholar
• Lawson CW, Fisher C, Gatter KC. An immunohistochemical study of differentiatio n in malignant ®brous histiocytoma. Histopathology, 1987;11:375±383.
   Google Scholar
• Litzky LA, Brooks JJ. Cytokeratin immunoreactivity in malignant ®brous histiocytoma and spindle cell tumors: comparison between frozen and paraf®n-embedded tissues. Mod Pathol. 1992;5:30±34.
   PubMedGoogle Scholar
• Miettinen M, Soini Y. Malignant ®brous histiocytoma: heterogeneous patterns of intermediate ®lament proteins by immunohistochemistry. Arch Pathol Lab Med. 1989;113:1363±1366.
   Google Scholar
• Rosenberg AE, O’Connell JX, Dickersin GR, Bhan AK. Expression of epithelial markers in malignant ®brous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol. 1993;24:284±293.
   Google Scholar
• Swanson PE, Dehner LP, Sirgi KE, Wick MR. Cytokeratin immunoreactivity in malignant tumors of bone and soft tissue: a reappraisal of cytokeratin as a reliable marker in diagnostic immunohistochemistry. Appl Immunohistochem. 1994;2:103±112.
   Google Scholar
• Miettinen M. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma. Arch Pathol Lab Med. 1988;112:637±640.
   Google Scholar
• Norton AJ, Thomas JA, Isaacson PG. Cytokeratin-speci®c monoclonal antibodies are reactive with tumours of smooth muscle derivation: an immunohistochemical and biochemical study using antibodies to intermediate ®lament cytoskeletal proteins. Histopathology. 1987;11:487±499.
   Google Scholar
• Coindre JM, de Mascarel A, Trojani M, et al. Immunohistochemical study of rhabdomyosarcoma: unexpected staining with S100 protein and cytokeratin. J Pathol. 1988;155:127±132.
   Google Scholar
• Miettinen M, Rapola J. Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors: expression of cytokeratin and the 68-kD neuro®lament protein. Am J Surg Pathol. 1989;13:120±132.
   Google Scholar
• Gray MH, Rosenberg AE, Dickersin GR, et al. Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol. 1990;21:212±217.
   Google Scholar
• Prescott RJ, Banerjee SS, Eyden BP, et al. Cutaneous epithelioid angiosarcoma: a clinicopathological study of four cases. Histopathology. 1994;25:421±429.
   Google Scholar
• Wenig BM, Abbondanza SL, Heffas CS. Epithelioid angiosarcoma of the adrenal glands: a clinicopathologic study of nine cases with a discussion of the implications of ®nding `epithelial-speci®c’ markers. Am J Surg Pathol. 1994;18:62±73.
   PubMed Web of Science ®Google Scholar
• Cof®n CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary in¯ammatory myo®broblastic tumor (in¯ammatory pseudotumor): a clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;19:859±872.
   Google Scholar
• Meis JM, Enzinger FM. In¯ammatory ®brosarcoma of the mesentery and retroperitoneum: a tumor closely simulating in¯ammatory pseudotumor. Am J Surg Pathol. 1991;15:1146±1156.
   Google Scholar
• Von Koskull H, Virtanen I. Induction of cytokeratin expression of human mesenchymal cells. J Cell Physiol. 1987;133:321.
   PubMed Web of Science ®Google Scholar
• Leader M, Collins M, Patel J, et al. Desmin: its value as a marker of muscle derived tumors using a commercial antibody. Virchows Arch A. 1987;411:345±359.
   Google Scholar
• Regezi JA, Zarbo RJ, Tomich CE. Immunopro®le of benign and malignant ®brohistiocytic tumors. J Oral Pathol. 1987;16:260±265.
   Google Scholar
• Truong LD, Rangdaeng S, Cagle P, et al. The diagnostic utility of desmin. Am J Clin Pathol. 1990;93:430±431.
   Google Scholar
• Weiss LM, Arber DA, Chang KL, CD68: a review. Appl Immunohistochem. 1994;2:2±8.
   Google Scholar
• Hanson CA, Jaszcz W, Kersey JH, et al. True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis. Br J Haematol. 1989;73:187±198.
   Google Scholar
• Hsu S-M, Ho YS, Hsu PL. Lymphomas of true histiocytic origin: expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis. Am J Pathol. 1991;138:1389±1404.
   Google Scholar
• Binder SW, Said JW, Shintaku IP, et al. A histiocyte-speci®c marker in the diagnosis of malignant ®brous histiocytoma: use of monoclonal antibody KP1 (CD68). Am J Clin Pathol. 1992;97:759±763.
   Google Scholar
• McHugh M, Miettinen M. KP1 (CD68): Its limited speci®city for histiocytic tumors. Appl Immunohistochem. 1994;2:186±190.
   Google Scholar
• Tsang WY, Chan JK. KP1 (CD68) staining of granular cell neoplasms: is KP1 a marker for lysosomes rather than histiocytic lineage? Histopathology. 1992;21:84±86.
   Google Scholar
• Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417±2426.
   Google Scholar
• Greaves MF, Brown J, Molgaard HV, et al. Molecular features of CD34: a hematopoietic progenitor cell-associate d molecule. Leukemia. 1992;1:31±36.
   Google Scholar
• van de Rijn M, Rouse RV. CD34: a review. Appl Immunohistochem. 1994;2:71±80.
   Google Scholar
• Ramani P, Bradley NJ, Fletcher CDM. QBEND/ 10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraf®n sections. Histopathology. 1990;17:237±242.
   Google Scholar
• Aziza J, Mazerolles C, Selves J, et al. Comparison of the reactivitie s of monoclonal antibodies QBEND10 (CD34) and BNH9 in vascular tumors. Appl Immunohistochem. 1993;1:51±57.
   Google Scholar
• Suster S, Fisher C, Moran CA. Expression of bcl- 2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol. 1998;22:863±872.
   Google Scholar
• Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol. 1993;17:1039±1045.
   Google Scholar
• Brunnemann RB, Ro JY, OrdoÂñez NG, Mooney J, El-Naggar AK, Ayala A. Extrapleural solitary ®brous tumor: a clinicopathologic review of 24 cases. Mod Pathol. 1999;12:1034±1042.
   Google Scholar
• Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S, Hirose T, SanoT. Frequent expression of bcl-2 protein in solitary ®brous tumors. Jpn J Clin Oncol. 1998;28:86±91.
   Google Scholar
• Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991;96:25±31.
   Google Scholar
• Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathologic analysis of 155 cases with a proposal for an expanded de®nition of dedifferentiation. Am J Surg Pathol. 1997;21:271±281.
   Google Scholar
• Hisaoka M, Tsuji S, Hashimoto H, Aoki T, Uriu K. Dedifferentiated liposarcoma with an in¯ammatory malignant ®brous histiocytoma-like component present a leukemoid reaction. Pathol Int. 1997;47:6452±646.
   Google Scholar